Triggering receptor expressed on myeloid cells 2 variant is rare in late-onset Alzheimer's disease in Han Chinese individuals

Neurobiol Aging. 2014 Apr;35(4):937.e1-3. doi: 10.1016/j.neurobiolaging.2013.10.075. Epub 2013 Oct 11.

Abstract

Recent studies have reported that a rare mutation of triggering receptor expressed on myeloid cells 2 gene (TREM2 [rs75932628-T]) has significantly increased the risk of late-onset Alzhemier's disease (LOAD) in European-descendent population. To date, no study has investigated the association between rare mutations of TREM2 and LOAD risk in non-European population. Here, we sequenced exon2 of TREM2 in the northern Han Chinese population consisting of 1133 patients with LOAD and 1159 control subjects. Although, 4 novel mutations (c.102G>A: Val34Val, c.330C>T: Cys110Cys, c.342T>C: His114His, and c.343G>A: Gly115Ser) were identified in patients with LOAD, none of them exhibited significant association with LOAD risk after Bonferroni correction. Most importantly, the previously reported rare variants in European-descendent population including rs75932628-T (predicted to cause an R47H substitution) were absent in our cohort. These findings suggest that mutations in exon2 of TREM2 were unlikely to play a key role in the susceptibility of LOAD in the northern Han Chinese population.

Keywords: Alzheimer's disease; Association; Genetic; Mutation; TREM2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / genetics*
  • Asian People / genetics*
  • Cohort Studies
  • Exons / genetics
  • Genetic Predisposition to Disease / genetics*
  • Humans
  • Membrane Glycoproteins / genetics*
  • Mutation*
  • Receptors, Immunologic / genetics*
  • Risk

Substances

  • Membrane Glycoproteins
  • Receptors, Immunologic
  • TREM2 protein, human